Alpha 2.0
Login Register
» Authors » A McGeer

A McGeer

Explore the profile of A McGeer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 149
Citations 3858
Followers 0
Related Specialties
Infectious Diseases
Public Health
Microbiology
Top 10 Co-Authors
D E Low
A E Simor
K Green
M Loeb
M Kotb
B M Willey
A Norrby-Teglund
B Schwartz
T Mazzulli
A Simor
Published In
Infect Control Hosp Epidemiol
Can Commun Dis Rep
J Clin Microbiol
Clin Infect Dis
Antimicrob Agents Chemother
Affiliations
Soon will be listed here.
Recent Articles
1.
Epidemiology of healthcare-associated Pseudomonas aeruginosa in intensive care units: are sink drains to blame?
Volling C, Mataseje L, Grana-Miraglia L, Hu X, Anceva-Sami S, Coleman B, et al.
J Hosp Infect . 2024 Mar; 148:77-86. PMID: 38554807
Background: Pseudomonas aeruginosa (PA) is a common cause of healthcare-associated infection (PA-HAI) in the intensive care unit (ICU). Aim: To describe the epidemiology of PA-HAI in ICUs in Ontario, Canada,...
2.
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study
Muller M, Navarro C, Wilson S, Shulha H, Naus M, Lim G, et al.
Vaccine . 2024 Jan; 42(3):535-540. PMID: 38199921
MVA-BN is an orthopoxvirus vaccine that provides protection against both smallpox and mpox. In June 2022, Canada launched a publicly-funded vaccination campaign to offer MVA-BN to at-risk populations including men...
3.
Development of a tool to assess evidence for causality in studies implicating sink drains as a reservoir for hospital-acquired gammaproteobacterial infection
Volling C, Thomas S, Johnstone J, Maltezou H, Mertz D, Stuart R, et al.
J Hosp Infect . 2020 Sep; 106(3):454-464. PMID: 32898614
Background: Decades of studies document an association between Gammaproteobacteria in sink drains and hospital-acquired infections, but the evidence for causality is unclear. Aim: We aimed to develop a tool to...
4.
Sources of viral respiratory infections in Canadian acute care hospital healthcare personnel
Buckrell S, Coleman B, McNeil S, Katz K, Muller M, Simor A, et al.
J Hosp Infect . 2020 Jan; 104(4):513-521. PMID: 31954763
Background: Viral respiratory illnesses are common causes of outbreaks and can be fatal to some patients. Aim: To investigate the association between laboratory-confirmed viral respiratory infections and potential sources of...
5.
Product dose considerations for real-world hand sanitiser efficacy
Kenters N, Eikelenboom-Boskamp A, Hines J, McGeer A, Huijskens E, Voss A
Am J Infect Control . 2020 Jan; 48(5):503-506. PMID: 31924389
Background: Alcohol based hand rubs (ABHR) are extremely effective at reducing microbial contamination and have an essential role in best practice hand hygiene described by the World Health Organization. Methods:...
6.
Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults
LeBlanc J, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, et al.
J Med Microbiol . 2019 Jul; 69(2):256-264. PMID: 31264957
. The Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN SOS) has been performing active influenza surveillance since 2009 (ClinicalTrials.gov identifier: NCT01517191). Influenza A and B viruses...
7.
The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada
Nichols M, Andrew M, Ye L, Hatchette T, Ambrose A, Boivin G, et al.
Clin Infect Dis . 2018 Dec; 69(6):970-979. PMID: 30508064
Background: Recent studies have demonstrated the possibility of negative associations between prior influenza vaccines and subsequent influenza vaccine effectiveness (VE), depending on season and strain. We investigated this association over...
8.
Immunogenicity and reactogenicity of high- vs. standard-dose trivalent inactivated influenza vaccine in healthcare workers: a pilot randomized controlled trial
Volling C, Coleman B, Katz K, Simor A, Muller M, Powis J, et al.
Clin Microbiol Infect . 2018 May; 25(2):217-224. PMID: 29783025
Objectives: To compare immunogenicity, reactogenicity and acceptability of high- and standard-dose trivalent inactivated influenza vaccine (HDTIV, SDTIV) in 18- to 64-year-olds. Methods: We randomized 18- to 64-year-olds to HDTIV or...
9.
Resistance patterns of Enterobacteriaceae in urines are similar in symptomatic and asymptomatic patients
Romero Palacios A, Al Dhufairi F, Ellis C, Smyth D, Mieusement L, McGeer A, et al.
J Hosp Infect . 2018 Feb; 99(4):419-421. PMID: 29432819
Antibiograms of urine cultures are being used to guide empiric treatment for urinary tract infections (UTIs). However, roughly 50% of urine cultures are from patients with asymptomatic bacteriuria (ABU). It...
10.
Optimal hand washing technique to minimize bacterial contamination before neuraxial anesthesia: a randomized control trial
Siddiqui N, Friedman Z, McGeer A, Yousefzadeh A, Carvalho J, Davies S
Int J Obstet Anesth . 2017 Mar; 29:39-44. PMID: 28341129
Introduction: Infectious complications related to neuraxial anesthesia may result in adverse outcomes. There are no best practice guidelines regarding hand-sanitizing measures specifically for these procedures. The objective of this study...